NCT00205920View on ClinicalTrials.gov

Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

September 30, 2006

Study Completion Date

May 31, 2007

Conditions
Pulmonary Emphysema
Interventions
BIOLOGICAL

BLVR Hydrogel

10 mL BLVR Hydrogel

Trial Locations (1)

3430 EM

St. Antonius Ziekenhuis, Nieuwegein

Sponsors

Lead Sponsor

Aeris Therapeutics
All Listed Sponsors
lead

Aeris Therapeutics

INDUSTRY

NCT00205920 - Netherlands 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation | Biotech Hunter | Biotech Hunter